JPRN-UMIN000009275
Recruiting
Phase 2
PhaseII study of maintenance S-1 after chemotherapy with platinium+pemetrexed in advanced nonsquamous NSCLC. - PhaseII study of maintenance S-1 after chemotherapy with platinium+pemetrexed in advanced nonsquamous NSCLC.
Conditionson Squamous Non Small Cell Lung Cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- on Squamous Non Small Cell Lung Cancer
- Sponsor
- Kansai Medical University
- Enrollment
- 22
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Interstitial pneumonia or pulmonary fibrosis on chest X\-ray 2\) History of serious drug allergy 3\)Patients with active double cancer 4\)Patients with pleural or pericardial effusion ,or ascites 5\)Being treated with flucytosine. 6\) History of serious infection 7\)History of HBs antigen 8\)Patients with significant complications a) Uncontrolled angina pectoris, myocardial infarction, heart failure within 3 months b)Uncontrolled diabetes or hypertension c)Current severe infection, or suspicious of severe infection d) Patients whose participation in the trial is judged to be inappropriate by the attending doctor. (e.g., ileus, bleeding tendency, diarrhea and varicella) 9 )Symptomatic brain metastases 10\)Patients with pregnancy or lactation 11\)patients whom it is judged to have difficulty in participation in study because of psychosis or neurologic disease 12\)Patients whose participation in the trial is judged to be inappropriate by the attending doctor.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Maintenance Chemotherapy With S-1, Locally Advanced Esophageal Cancer Receiving Definitive CCRTLocally Advanced Unresectable Esophageal CancerNCT06598917China Medical University Hospital60
Completed
Phase 2
ESOX trialadenocarcinoma of the esophagogastric junctionJPRN-jRCTs051180192Watanabe Masayuki50
Recruiting
Phase 2
A phase II study of systemic chemotherapy with S-1 plus oxaliplatin followed by surgery in T3/T4a and/or lymph node-positive advanced adenocarcinoma of the esophagogastric junctioJPRN-UMIN000020815Cancer Institute Hospital, Gastroenterological Chemotherapy Department50
Completed
Phase 2
A phase II study of systemic chemotherapy with S-1 and Oxaliplatin followed by gastrectomy with D2 or D2 plus limited para-aortic lymph node dissection in HER2 negative advanced gastric or esophagogastric junction cancer with extensive lymph node metastasisGastric cancerJPRN-UMIN000027506Cancer Institute Hospital35
Active, not recruiting
Phase 2
SOX-D2 studyJPRN-jRCTs051180198Sano Takeshi35